GlaxoSmithKline (GSK)

Add to Watchlists
Create an Alert
52.51 -0.31  -0.59% NYSE Apr 17, 8:00PM BATS Real time Currency in USD

GlaxoSmithKline Revenue (TTM):

41.76B for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

GlaxoSmithKline Revenue (TTM) Chart

Export Data
Save Image

GlaxoSmithKline Historical Revenue (TTM) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 41.76B
Sept. 30, 2013 41.33B
June 30, 2013 41.49B
March 31, 2013 41.42B
Dec. 31, 2012 42.18B
Sept. 30, 2012 41.98B
June 30, 2012 42.45B
March 31, 2012 43.16B
Dec. 31, 2011 43.11B
Sept. 30, 2011 43.51B
June 30, 2011 43.21B
March 31, 2011 43.04B
Dec. 31, 2010 43.59B
Sept. 30, 2010 45.44B
June 30, 2010 45.47B
March 31, 2010 46.07B
Dec. 31, 2009 44.63B
Sept. 30, 2009 41.61B
June 30, 2009 41.42B
March 31, 2009 Upgrade
Dec. 31, 2008 Upgrade
Sept. 30, 2008 Upgrade
June 30, 2008 Upgrade
March 31, 2008 Upgrade
Dec. 31, 2007 Upgrade
   
Sept. 30, 2007 Upgrade
June 30, 2007 Upgrade
March 31, 2007 Upgrade
Dec. 31, 2006 Upgrade
Sept. 30, 2006 Upgrade
June 30, 2006 Upgrade
March 31, 2006 Upgrade
Dec. 31, 2005 Upgrade
Sept. 30, 2005 Upgrade
June 30, 2005 Upgrade
March 31, 2005 Upgrade
Dec. 31, 2004 Upgrade
Sept. 30, 2004 Upgrade
June 30, 2004 Upgrade
March 31, 2004 Upgrade
Dec. 31, 2003 Upgrade
Sept. 30, 2003 Upgrade
June 30, 2003 Upgrade
March 31, 2003 Upgrade
Dec. 31, 2002 Upgrade
Sept. 30, 2002 Upgrade
June 30, 2002 Upgrade
March 31, 2002 Upgrade
Dec. 31, 2001 Upgrade
Sept. 30, 2001 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Revenues

Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.

While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
Learn More

Get data for
Advertisement

GSK Revenue (TTM) Benchmarks

Companies
AstraZeneca 25.71B
Eli Lilly 23.11B
Johnson & Johnson 71.31B

GSK Revenue (TTM) Range, Past 5 Years

Minimum 41.33B Sep 2013
Maximum 46.07B Mar 2010
Average 42.99B
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.